C-peptide and diabetic neuropathy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.9, 2003-09, pp. : 1471-1488

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Duloxetine in diabetic neuropathy

By Smith Timothy R

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 215-223

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for diabetic neuropathy

By Tahrani Abd A Askwith Trevor Stevens Martin J

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 661-683

Informa Healthcare

Access to resources Recommend Favorite

C-Peptide and its Correlation to Parameters of Insulin Resistance in the Metabolic Syndrome

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 8, 2011-12 ,pp. : 921-927

Bentham Science Publishers

Access to resources Recommend Favorite

Growth Factors as Therapeutics for Diabetic Neuropathy

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 47-59

Bentham Science Publishers

Access to resources Recommend Favorite

Is C-Peptide Replacement the Missing Link for Successful Treatment of Neurological Complications in Type 1 Diabetes?

Current Drug Targets, Vol. 9, Iss. 1, 2008-01 ,pp. : 37-46

Bentham Science Publishers

Access to resources Recommend Favorite